% 215 -32% 361 730 -51% Adjusted EBITDA Margin (%) 4.4% 6.8% -2.4% 7.6% -3.2% 5.9% 8.2% -2.3% Net Profit -36 67 -154% 20 -280% -16 131 -112% Item from raw materials derogation 14 -2,004 -101% 2 600% 16
the Infrastructure Fund of Japan in September 2018. This resulted in the steady amount of overall electricity generated. There were also a profit from the sales of the aforementioned assets before tax
biodiesel was 76.68% in 2018. This was similar to 75.28% in 2017 and all previous years. The profit has seen steady growth in this sector. 2.2 The refining service for Edible Oil has ratio of cost of refining
refining services to revenue for RBD Palm oil for biodiesel was 76.68% in 2018. This was similar to 75.28% in 2017 and all previous years. The profit has seen steady growth in this sector. 2.2 The refining
(6)% Fibers 59 46 55 8% 201 208 (3)% Feedstock 114 117 78 47% 410 177 132% Core EBIT 155 139 136 14% 551 374 47% Core Net Profit after Tax and NCI (US$ M) 110 95 84 31% 360 206 75% Core Net Profit
(excluding equipment rental) of 45.2% , up from 44.7% in FY17. With continued network investment, net profit was reported at Bt29,682mn, slightly declining 1.3% YoY. For FY19, AIS expects to grow mid- single
, following the decline in profit before tax. The effective tax rate was 18.9% increasing from 18.0% in 3Q21 due to expiring tax benefits and remain steady from 2Q22. SG&A expenses recorded Bt5,633mn, increased
, following the decline in profit before tax. The effective tax rate was 18.9% increasing from 18.0% in 3Q21 due to expiring tax benefits and remain steady from 2Q22. SG&A expenses recorded Bt5,633mn, increased
, following the decline in profit before tax. The effective tax rate was 18.9% increasing from 18.0% in 3Q21 due to expiring tax benefits and remain steady from 2Q22. SG&A expenses recorded Bt5,633mn, increased
enhanced device margin. AIS reported a net profit of Bt8,788mn, increasing 7.9% YoY reflecting strong operating performance, while increasing 2.5% QoQ from higher foreign exchange rate gain. 3Q24 MD&A